Fetal Hormone Tied To Devastating Morning Sickness

Ten genes now tie to the most brutal form of “morning sickness,” pointing to a clear biological pathway—and a future where doctors can predict and blunt it before it wrecks a pregnancy.

Story Snapshot

Largest genetic study links 10 genes to hyperemesis gravidarum, the severe end of pregnancy sickness
Growth differentiation factor 15 (GDF15) stands out as the key signal and likely driver
Evidence shows much of the hormone comes from the fetus and mothers vary in sensitivity
Findings move care away from stigma and toward screening, early warning, and targeted therapy

What the new study actually found

Researchers analyzed genetic data from 10,974 women with hyperemesis gravidarum and 461,461 controls. The team reported nine new genetic links, bringing the total to 10 risk genes connected with severe pregnancy nausea and vomiting. The study used a multi-ancestry design and is the largest to date on this topic. It strengthens the idea that hyperemesis gravidarum has a measurable genetic backbone, not just lifestyle or stress triggers.

Earlier work set the stage for this jump. Prior genetic studies first pointed to two genes, growth differentiation factor 15 and insulin-like growth factor binding protein 7, which both relate to placental signals and appetite control. Those signals match what women with hyperemesis gravidarum describe: relentless nausea, vomiting, and weight loss during the weeks when the placenta ramps up.

GDF15: the hormone at the center of the storm

Scientists have now traced much of the biology back to a single hormone. Growth differentiation factor 15 rises in pregnancy and appears to drive nausea severity. A study in the journal Nature showed that most of this hormone in the mother’s blood comes from the fetus. The study also found that a mother’s prior exposure to growth differentiation factor 15 changes her sensitivity, which helps explain why some women get far sicker than others, even across pregnancies.

That model fits real life. Women with a sister who had hyperemesis gravidarum face a much higher risk, which points to both shared genes and shared sensitivity. Family patterns, plus a clear hormone signal from the placenta, line up with the genetics. The message lands hard: this is not “in your head.” It is a biologic stress that can spiral without fast support.

Hype, limits, and the next right steps

News headlines love long gene lists, but the strongest proof still centers on growth differentiation factor 15 and maternal sensitivity. The nine new genes expand the map, yet they likely act through that core pathway or related placental biology. The Nature paper’s hormone and sensitivity data beat vague “gene found” claims because it connects cause to effect. Policy and funding should back trials that test growth differentiation factor 15–targeted drugs and step-up care for high-risk women.

Good science also keeps guardrails. Not every pregnancy with nausea is hyperemesis gravidarum. Studies must keep cases tight and confirm each new gene in fresh groups. Hospitals should track outcomes and share data to refine care faster. If we follow the evidence, we can turn a feared condition into a managed risk. The path is clear: measure the hormone, know the genes, act early, and spare mothers the worst weeks of their lives.